Kamay Ventures

Corporate VC Buenos Aires, Argentina · Founded 2020

Backed by Coca-Cola and Arcor to invest in digital transformation for the consumer value chain.

About Kamay Ventures

Kamay Ventures is a Buenos Aires-based corporate venture capital fund backed jointly by Coca-Cola and Arcor, two of the largest consumer-products operators in Latin America. The fund writes seed checks in the $250K to $1M range and focuses on digital transformation across the consumer value chain, with healthcare interest concentrated in wellness and consumer health rather than clinical or AI-native plays. Because Kamay is a strategic CVC tied to two major beverage and snack companies, the investment logic is concentrated on opportunities that connect to the parents’ supply chains, retail distribution, consumer-data infrastructure, or brand portfolios. For healthcare and wellness founders, that means the fit is real for businesses building health-adjacent consumer brands, distribution-tech, or digital products that integrate with FMCG channels, and the fit is poor for B2B clinical software or research-stage therapeutics. The geographic focus is Latin America, with Coca-Cola’s and Arcor’s operating reach giving Kamay a regional sourcing and partnership advantage. The right founder profile is a consumer wellness or digital health brand with credible early traction, a defensible product proposition, and a clear thesis on how distribution through Coca-Cola or Arcor channels accelerates scale. The wrong fit is a clinical AI startup, a medical device, or any business where the FMCG channel is irrelevant. The right entry path is through Buenos Aires and Sao Paulo founder networks, through corporate-development teams at Coca-Cola Latin America and Arcor, and through warm introductions from co-investors at firms like Globant Ventures, NXTP, and Cygnus. When pitching, lead with the strategic fit to Coca-Cola or Arcor distribution and quantify what that partnership unlocks, then connect to standalone unit economics and brand defensibility. Avoid pitching Kamay as a generic seed check; the strategic angle is the differentiator. Caveats: as with any CVC, founders should manage strategic exclusivity terms carefully and think about how dependent they want to be on a single corporate partner, particularly when that partner has competitors who could be future customers or acquirers. Use Kamay when the FMCG channel is a genuine accelerator for your wellness or consumer health business, not as a default Latin American seed check.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Other portfolio companies

Companies in Kamay Ventures's portfolio not currently in our directory.

Team

Gabriela Ruggeri
Co-founder & Managing Partner
Antonio Pena
Co-founder & Managing Partner

Pitch / review this investor

Have you raised from Kamay Ventures? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
AI Tool Finder
AI-powered search. Results may not be comprehensive.